McGrathBMWesselsPBellECUlrichMSilverstonePH. Neurobiological findings in bipolar II disorder compared with those in bipolar I disorder. Can J Psychiatry2004;49:794–801.
2.
HadjipavlouGMokHYathamLN. Bipolar II disorder: An overview of recent developments. Can J Psychiatry2004;49:802–12.
3.
RobinsLNHelzerJEWeissmanMMOrvaschelHGruenbergEBurkeJDRegierDA. Lifetime prevalence of specific psychiatric disorders in three sites. Arch Gen Psychiatry1984;41:949–58.
4.
KesslerRCMcGonagleKAZhaoSNelsonCBHughesMEshlemanS, and others. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry1994;51:8–19.
5.
AngstJ.The emerging epidemiology of hypomania and bipolar II disorder. J Affect Disord1998;50:143–51.
6.
HibbelnJR. Fish consumption and major depression. Lancet1998;351:1213.
7.
HibbelnJR. Seafood consumption, the DHA content of mothers' milk and prevalence rates of postpartum depression: A cross-national, ecological analysis. J Affect Disord2001;69:15–29.
8.
StollALSeverusWEFreemanMPRueterSZboyanHADiamondE, and others. Omega 3 fatty acids in bipolar disorder: A preliminary double-blind placebo-controlled trial. Arch Gen Psychiatry1999;56:407–12.
9.
NemetsBStahlZBelmakerRH. Addition of Omega-3 Fatty Acid to maintenance medication treatment for recurrent unipolar depressive disorder. Am J Psychiatry2002;159:477–9.
10.
PeetMHorrobinDF. A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with depression despite adequate treatment with standard drugs. Arch Gen Psychiatry2002;59:913–9.
11.
EdwardsRPeetMShayJHorrobinD.Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients. J Affect Disord1998;48:149–55.
12.
MaesMChristopheADelangheJAltamuraCNeelsHMeltzerHY. Lowered Omega-3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients. Psychiatry Res1999;85:275–91.
13.
LamDHWatkinsERHaywardPBrightJWrightKKerrN, and others. A randomized controlled study of cognitive therapy for relapse prevention for bipolar affective disorder: Outcome of the first year. Arch Gen Psychiatry2003;60:145–52.
14.
ParkerGParkerK.Which antidepressants flick the switch? A review. Aust N Z J Psychiatry2003;37:464–8.
15.
ParkerG.Do the newer antidepressants have mood stabilizing properties? [letter]. Aust N Z J Psychiatry2002;36:427–8.